Gold chess pieces and stock charts
(Source: Adobe Stock. Generated by AI)

On episode 6 of The 5-Minute Investor Podcast, Stockhouse columnists Jonathon Brown and Trevor Abes discuss the value propositions behind two prospective stocks, including First Mining Gold (TSX:FF), whose market capitalization pales in comparison to its almost US$40 billion in mineral resources under development.

Click here for the full story.

By the ounce

At the time of writing on Tuesday, the price of gold sat at US$3,245, up from US$3,012,50 per ounce in our April 9 report, according to data from The Globe and Mail, as Trump’s tariff stop-and-starts continue to erode the market’s patience.

This week in gold

Noted Canadian junior mining investor Michael Gentile picked up shares of Leviathan Gold (TSXV:LVX), a mineral explorer in Australia and Bosnia and Herzegovina surrounded by mines and established deposits.

Laurion Mineral Exploration (TSXV:LME) shared a series of updates about its richly-mineralized Ishkõday project in Greenstone, Ontario, demonstrating management’s alignment with shareholder value.

Grande Portage Resources (TSXV:GPG) makes for a compelling buy thanks to its US$6 billion in resources, a stock price lagging gold’s recent run-up and a 2025 exploration program aiming to increase market recognition through the drill bit.

  1. New Found Gold (TSXV:NFG) | 13,200+ views.
  2. Laurion Mineral Exploration (TSXV:LME) | 8,800+ views.
  3. West Red Lake Gold Mines (TSXV:WRLG) | 7,900+ views.
  4. Calibre Mining (TSX:CXB) | 6,900+ views.
  5. Maritime Resources (TSXV:MAE) | 6,400+ views.
  6. Freegold Ventures (TSX:FVL) | 5,700+ views.


Join the discussion: Find out what everybody’s saying about the stories in this week’s gold report on Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image, generated by AI: Adobe Stock)


More From The Market Online

3 ambitious pharma stocks near commercialization

A concise look at Abivax, Q32 Bio and Achieve Life Sciences, three pharma stocks keen to solve some of healthcare's most vital unmet needs.

The 5-Minute Investor Podcast, Ep. 75: Showstopping movie stocks

Listen to episode 75 of The 5-Minute Investor Podcast, featuring analysis on movie stocks Dolby and Marcus Corp.

@ the Bell: Markets navigate new tariffs and falling yields

Canada’s main stock index ended Monday with a little bump as investors weighed the impact of...

2 micro-cap stocks securing North America’s critical minerals future

Kickstart your due diligence on Tactical Resources and Honey Badger Silver, a pair of high-quality, early-stage critical minerals stocks.